4//SEC Filing
Shawah Robert G. 4
Accession 0001104659-25-010181
CIK 0001736243other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:47 PM ET
Size
5.6 KB
Accession
0001104659-25-010181
Insider Transaction Report
Form 4
Shawah Robert G.
Chief Financial Officer
Transactions
- Award
Stock Option
2025-02-05+145,500→ 145,500 totalExercise: $0.80Exp: 2035-02-05→ Common Stock (145,500 underlying)
Footnotes (1)
- [F1]On February 5, 2025, the Reporting Person was granted stock options to purchase 145,500 shares of the Issuer's common stock. These options vest immediately.
Documents
Issuer
Acurx Pharmaceuticals, Inc.
CIK 0001736243
Entity typeother
Related Parties
1- filerCIK 0001601121
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:47 PM ET
- Size
- 5.6 KB